Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Breast Neoplasms
  • Neoplasms, Hormone-Dependent
  • Nitriles
  • Tamoxifen
  • Triazoles

abstract

  • Interpretation of this cohort analysis suggests that LET improves DFS and distant DFS even when there has been a substantial period of time since the discontinuation of prior adjuvant tamoxifen.

publication date

  • September 15, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2007.11.6798

PubMed ID

  • 18332475

Additional Document Info

start page

  • 1948

end page

  • 55

volume

  • 26

number

  • 12